<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To report a case of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) following toxoplasma <z:e sem="disease" ids="C0008513" disease_type="Disease or Syndrome" abbrv="">retinochoroiditis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: Interventional case report </plain></SENT>
<SENT sid="2" pm="."><plain>METHOD: The patient was a 24-year-old female with an attack of <z:hpo ids='HP_0000572'>visual loss</z:hpo> due to toxoplasma <z:e sem="disease" ids="C0008513" disease_type="Disease or Syndrome" abbrv="">retinochoroiditis</z:e> concomitant with branch <z:chebi fb="46" ids="15035">retinal</z:chebi> vein occlusion </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0035333" disease_type="Disease or Syndrome" abbrv="">Retinitis</z:e> resolved with anti-toxoplasma treatment </plain></SENT>
<SENT sid="4" pm="."><plain>However, a recurrent episode of BRVO and <z:hpo ids='HP_0007902'>vitreous hemorrhage</z:hpo> occurred later </plain></SENT>
<SENT sid="5" pm="."><plain>RESULT: In systemic evaluation, evidence of APS was detected, including high titers of anti-<z:chebi fb="0" ids="28494">cardiolipin</z:chebi> antibody, increased beta-2 microglobulin and anti-toxoplasma IgG antibody, and also low titers of C3, C4, and CH50 </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: <z:e sem="disease" ids="C0040561" disease_type="Disease or Syndrome" abbrv="">Ocular toxoplasmosis</z:e> should be included in the list of etiologies of secondary APS </plain></SENT>
<SENT sid="7" pm="."><plain>Systemic evaluation for detection of APS is a necessary approach to patients with toxoplasma <z:e sem="disease" ids="C0008513" disease_type="Disease or Syndrome" abbrv="">retinochoroiditis</z:e> and concomitant vascular accident </plain></SENT>
</text></document>